Catalyst Capital Advisors’s Teladoc Health TDOC Stock Holding History

Catalyst Capital Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,630	Closed	-$1.49M	–	397
2022 Q1	$1.49M	Buy	20,630 +11,500	+126%	+$828K	0.06%	146
2021 Q4	$838K	Buy	9,130 +230	+3%	+$27.5K	0.04%	171
2021 Q3	$1.13M	Hold	8,900	–	–	0.06%	161
2021 Q2	$1.48M	Hold	8,900	–	–	0.07%	158
2021 Q1	$1.62M	Hold	8,900	–	–	0.09%	137
2020 Q4	$1.78M	Hold	8,900	–	–	0.1%	115
2020 Q3	$1.95M	Hold	8,900	–	–	0.11%	102
2020 Q2	$1.7M	Buy	+8,900	New	+$1.56M	0.09%	111
2019 Q2	–	Sell	-91	Closed	-$5K	–	473
2019 Q1	$5K	Hold	91	–	–	﹤0.01%	365
2018 Q4	$5K	Sell	91 -39	-30%	-$2.39K	﹤0.01%	366
2018 Q3	$11K	Buy	130 +55	+73%	+$3.92K	﹤0.01%	328
2018 Q2	$4K	Buy	75 +25	+50%	+$1.22K	﹤0.01%	462
2018 Q1	$2K	Buy	+50	New	+$1.89K	﹤0.01%	466

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Catalyst Capital Advisors's TDOC Position: Q2 2022 in Review

Catalyst Capital Advisors sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 20,630 shares — an estimated $1.49M sold.

Catalyst Capital Advisors first reported a position in TDOC in Q1 2018 and held it in 13 quarters. The position peaked at $1.95M in Q3 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

Catalyst Capital Advisors reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
Catalyst Capital Advisors sold 20,630 Teladoc Health shares in Q2 2022, an estimated $1.49M.
Catalyst Capital Advisors first reported a position in Teladoc Health in Q1 2018 and held it in 13 quarters.
Catalyst Capital Advisors's Teladoc Health position peaked at $1.95M in Q3 2020.
551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Catalyst Capital Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.